|
An Additional Exempt Distribution -2022-06-07
|
5
|
Resverlogix Corp.
|
Jun 08, 2022 11:53AM
|
|
Re: Clinical trials site
|
5
|
Zenith Epigenetics
|
Aug 20, 2022 07:05AM
|
|
Re: Comments on the AGM
|
5
|
Resverlogix Corp.
|
Nov 08, 2019 11:30AM
|
|
Re: News! - COVID 19 pre-clinical and clinical research trials
|
5
|
Resverlogix Corp.
|
Jun 01, 2020 09:10AM
|
|
Re: Clinical trials site
|
5
|
Zenith Epigenetics
|
Aug 20, 2022 08:34AM
|
|
Re: Missed Opportunity
|
5
|
Resverlogix Corp.
|
Apr 02, 2024 09:15AM
|
|
Re: How many other "Alex Kopacz's" are out there...as we wait our turn on the tarmac?
|
5
|
Resverlogix Corp.
|
Apr 27, 2021 11:55AM
|
|
Additional Exempt Distribution- 2023-03-31
|
5
|
Zenith Epigenetics
|
Apr 10, 2023 07:09PM
|
|
Re: Lu stepping down
|
5
|
Resverlogix Corp.
|
Feb 21, 2024 07:19PM
|
|
Re: Recent findings point to BET protein and ACE2 inhibition as possible means to slow and reduce the impact of COVID-19....
|
5
|
Resverlogix Corp.
|
Mar 23, 2020 06:11PM
|
|
Re: The 3 inflection points: SSRA, Top-Line, Full Data
|
5
|
Resverlogix Corp.
|
Sep 15, 2018 01:03PM
|
|
Replace "Stroke Mace" with "CHF Mace"
|
5
|
Resverlogix Corp.
|
Nov 18, 2019 09:11AM
|
|
Re: RVXCF New 52 week high, $3.59 USD....
|
5
|
Resverlogix Corp.
|
Apr 23, 2019 10:33AM
|
|
Re: Another Exempt Distribution -2022-06-02
|
5
|
Resverlogix Corp.
|
Jun 06, 2022 08:46AM
|
|
Re: More Exempt Distribution Investments
|
5
|
Zenith Epigenetics
|
Jan 05, 2024 05:24PM
|
|
Exempt Distribution- 2021-04-12
|
5
|
Resverlogix Corp.
|
Apr 14, 2021 11:18AM
|
|
Re: Why is "Going it Alone" out of the question??
|
5
|
Resverlogix Corp.
|
Aug 14, 2020 11:50AM
|
|
Re: BETonMACE Placebo Estimate
|
5
|
Resverlogix Corp.
|
Feb 20, 2019 09:30AM
|
|
FDA approves "empagliflozin" for reducing risk of cardiovascular death, hospitalization among adult HFpEF patients
|
5
|
Resverlogix Corp.
|
Apr 05, 2022 10:37AM
|
|
Re: Why is "Going it Alone" out of the question??
|
5
|
Resverlogix Corp.
|
Aug 14, 2020 12:44PM
|
